Logo image
Intraperitoneal medetomidine: a novel analgesic strategy for postoperative pain management in pregnant sheep
Journal article   Peer reviewed

Intraperitoneal medetomidine: a novel analgesic strategy for postoperative pain management in pregnant sheep

F.R. Murdoch, G.L. Maker, I. Nitsos, G.R. Polglase and G.C. Musk
Laboratory Animals, Vol.47(1), pp.66-70
2013
url
Link to Published Version *Subscription may be requiredView

Abstract

The absorption of medetomidine released by continuous infusion from an osmotic pump in the abdominal cavity was studied in pregnant sheep during the 24 h postoperative period. Additionally pain and sedation was assessed. Eleven sheep were studied: six were treated with a medetomidine loaded osmotic pump delivering 10 mu L/h (3 mu g/kg/h medetomidine); and five with a saline loaded osmotic pump (control). Serial blood samples were taken and analysed to determine plasma medetomidine levels. Medetomidine was absorbed from the peritoneal cavity and a steady plasma concentration was achieved within 10 h, mean (SD) peak concentration was 2.87 (0.22) ng/mL. Sheep receiving medetomidine analgesia had significantly lower pain scores at 10 h than controls. Four control sheep required rescue analgesia, compared with 0 in the treatment group. Delivery of 3 mu g/kg/h medetomidine by an intraperitoneal osmotic pump to pregnant sheep in the 24 h postoperative period provides adequate plasma concentrations of medetomidine for analgesia without sedation.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.43 Anesthesiology
1.43.1642 Veterinary Anesthesia
Web Of Science research areas
Veterinary Sciences
Zoology
ESI research areas
Plant & Animal Science
Logo image